Mumbai, Maharashtra Nov 24, 2025 (Issuewire.com) - Krishgen Biosystems Private Limited, India, in collaboration with EPISKIN SA, France (LOreal Research & Innovation; world leader's in tissue engineering for in vitro human skin and epithelial models) will host the Grand Finale of the BioReImagine Innovation Challenge 2025 on Thursday, November 27, 2025 - and we invite members to attend for an evening of innovation data, networking and keynote talks.
The event marks the culmination of Indias first national-level innovation challenge promoting ethical, non-animal testing research using EPISKINs reconstructed human tissue models. The top three finalists from across India will present their proof-of-concept projects to an expert jury comprising scientists, industry leaders, and regulatory professionals. Keynote sessions by senior ADMET and life-science experts will highlight how reconstructed human tissue technologies are transforming predictive toxicology, safety assessment, and regulatory science.
BioReimagine 2025 is a step toward Indias scientific future - where innovation and ethics go hand in hand to offer innovation in skin models in translational research for drug discovery, wound management and cosmetic applications, said Dr Kalpesh Jain, Director, Krishgen Biosystems Private Limited.
Date: November 27, 2025 | Time: 3:00 PM 7:00 PM | Venue: NIMHANS Convention Centre, Bengaluru
Know More At:
Media Contact
More On Newsinterestcorp ::
- Incite AI Revolutionizes AI Investing with Advanced Trading Technology for Forward-Thinking Investors
- Matchmaking Service Beau Brummell Introductions Shares Tips and Advice for Modern Dating
- Smart Movers Hamilton - The Smartest Way to Move
- Sharon Musgrave Releases eBook and Audiobook Editions of The 333 Myth Series: ARC II — The Quest
- Kristina’s Cache Chronicles a Remarkable Journey of Survival, Ingenuity, and Life in Alaska
KRISHGEN BIOSYSTEMS PRIVATE LIMITED
912249198700
Unit Nos 318 319 Shah and Nahar Off Dr E Moses Road Worli
Source :KRISHGEN BIOSYSTEMS PRIVATE LIMITED
This article was originally published by IssueWire. Read the original article here.